Polygenic modelling of treatment effect heterogeneity (Q98305099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

12 August 2020

title

Polygenic modelling of treatment effect heterogeneity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

12 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

12 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

12 August 2020

publication date

10 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

12 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease

12 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Use of Mendelian randomisation to assess potential benefit of clinical intervention

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

The UK Biobank resource with deep phenotyping and genomic data

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Detecting gene-gene interactions that underlie human diseases

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Power and predictive accuracy of polygenic risk scores.

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: A review

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

An Introduction to Statistical Learning

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Validating therapeutic targets through human genetics

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Factorial Mendelian randomization: using genetic variants to assess interactions

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Statistical pitfalls of personalized medicine

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Random forests of interaction trees for estimating individualized treatment effects in randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Mendelian randomization: nature's randomized trial in the post-genome era.

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.22347

7 January 2021

Identifiers

DOI

10.1002/GEPI.22347

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json

12 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32779269%20AND%20SRC:MED&resulttype=core&format=json